Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Broad Anti-Hepatitis C Virus (HCV) Antibody Responses Are Associated with Improved Clinical Disease Parameters in Chronic HCV Infection.

Journal of virology - 1 May 2016

Swann Rachael E, Cowton Vanessa M, Robinson Mark W, Cole Sarah J, Barclay Stephen T, Mills Peter R, Thomson Emma C, McLauchlan John, Patel Arvind H

Abstract excerpt

UNLABELLED: During hepatitis C virus (HCV) infection, broadly neutralizing antibody (bNAb) responses targeting E1E2 envelope glycoproteins are generated in many individuals. It is unclear if these antibodies play a protective or a pathogenic role during chronic infection. In this study, we investigated whether bNAb responses in individuals with chronic infection were associated with differences in clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Cross Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epitopes

Share to Hepatitis C Antibodies

Share to HLA-DQ Antigens

Share to Immunoglobulin G

Share to Liver Cirrhosis

Share to Viral Envelope Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 26912610
DOI: 10.1128/JVI.02669-15
PMCID: PMC4836347

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Broad Anti-Hepatitis C Virus (HCV) Antibody Responses Are Associated with Improved Clinical Disease Parameters in Chronic HCV Infection.PMID 26912610Read ↗

Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses.Semantic proximity Read ↗

Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potencySemantic proximity Read ↗

A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization ResistanceSemantic proximity Read ↗

Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).Semantic proximity Read ↗

Interplay of Host and Viral Genetic Variations in Modulating Antibody Responses to Genotype 3a Hepatitis C Virus: Implications for Vaccine DesignSemantic proximity Read ↗

Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.Semantic proximity Read ↗

Interplay of host and viral genetic variations in modulating antibody responses to genotype 3a hepatitis C virus: Implications for vaccine design.Semantic proximity Read ↗

Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistanceSemantic proximity Read ↗

Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral GenotypesSemantic proximity Read ↗

Defining Breadth of Hepatitis C Virus Neutralization.Semantic proximity Read ↗

Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent.Semantic proximity Read ↗

Hepatitis C virus E1 protein-specific linear B-cell epitopes, pan-genotype reactivity, and functional relevance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.